Targeting S100p inhibits colon cancer growth and metastasis by lentivirus-mediated RNA interference and proteomic analysis

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 709-716

  Jiang, Lei ^a   Lai, Yiu Kay ^b   Zhang, Jinfang ^c   Wang, Hua ^c   Lin, Marie C M ^c   He, Ming Liang ^c   Kung, Hsiang Fu ^c  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANOSINE DIPHOSPHATE; LENTIVIRUS VECTOR; PROTEIN S 100; PROTEIN S 100P; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; THIOREDOXIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; LENTIVIRUS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEOMICS; RNA INTERFERENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THIOREDOXINS; TUBULIN; TUMOR BURDEN; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960726340     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00008     Document Type: Article

References (36)

1. Khair G, Monson JR, Greenman J. (2007) Epithelial molecular markers in the peripheral blood of patients with colorectal cancer. Dis. Colon Rectum. 50:1188-1203.
2. Arumugam T, Ramachandran V, Logsdon CD. (2006) Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J. Natl. Cancer Inst. 98:1806-1818.
3. Arumugam T, Simeone DM, Van Golen K, Logsdon CD. (2005) S100P promotes pancreatic cancer growth, survival, and invasion. Clin. Cancer Res. 11:5356-5364.
4. Parkkila S, et al. (2008) The calcium-binding protein S100P in normal and malignant human tissues. BMC Clin. Pathol. 8:2.
5. Dowen SE, et al. (2005) Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am. J. Pathol. 166:81-92.
6. Guerreiro Da Silva ID, et al. (2000) S100P calciumbinding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int. J. Oncol. 16:231-240.
7. Birkenkamp-Demtroder K, et al. (2005) Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54:374-384.
8. Wang Q, et al. (2007) Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene. 26:6560-6565.
9. Rehbein G, Simm A, Hofmann HS, Silber RE, Bartling B. (2008) Molecular regulation of S100P in human lung adenocarcinomas. Int. J. Mol. Med. 22:69-77.
10. Wang G, et al. (2006) Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res. 66:1199-1207.
11. Schor AP, Carvalho FM, Kemp C, Silva ID, Russo J. (2006) S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncol. Rep. 15:3-6.
12. Fuentes MK, et al. (2007) RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis. Colon Rectum. 50:1230-1240.
13. Arumugam T, Simeone DM, Schmidt AM, Logsdon CD. (2004) S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J. Biol. Chem. 279:5059-5065.
14. Whiteman HJ, et al. (2007) The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res. 67:8633-8642.
15. Namba T, et al. (2009) Up-regulation of S100P expression by non-steroidal anti-inflammatory drugs and its role in anti-tumorigenic effects. J Biol. Chem. 284:4158-4167.
16. Chen Y, et al. (2007) Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology. 46:200-208.
17. Jiang L, et al. (2009) Down-regulation of stathmin is required for TGF-beta inducible early gene 1 induced growth inhibition of pancreatic cancer cells. Cancer Lett. 274:101-108.
18. Wozniak MA, Keely PJ. (2005) Use of threedimensional collagen gels to study mechanotransduction in T47D breast epithelial cells. Biol. Proced. Online. 7:144-161.
19. Li G, et al. (2009) Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics. 9:20-30.
20. Yamamoto Y, et al. (2005) Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma. Biochem. Biophys. Res. Commun. 333:223-229.
21. Bartling B, et al. (2007) S100A2-S100P expression profile and diagnosis of non-small cell lung carcinoma: impairment by advanced tumour stages and neoadjuvant chemotherapy. Eur. J. Cancer. 43:1935-1943.
22. Emberley ED, Murphy LC, Watson PH. (2004) S100 proteins and their influence on pro-survival pathways in cancer. Biochem. Cell Biol. 82:508-515.
23. Powis G, Montfort WR. (2001) Properties and biological activities of thioredoxins. Annu. Rev. Biophys. Biomol. Struct. 30:421-455.
24. Kakolyris S, et al. (2001) Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin. Cancer Res. 7:3087-3091.
25. Fernandes AP, et al. (2009) Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation. Histopathology. 55:313-320.
26. Cunnea P, et al. (2007) Increased expression of specific thioredoxin family proteins: a pilot immunohistochemical study on human hepatocellular carcinoma. Int. J. Immunopathol. Pharmacol. 20:17-24.
27. Nakamura H, et al. (2000) Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer. Cancer Detect. Prev. 24:53-60.
28. Noike T, Miwa S, Soeda J, Kobayashi A, Miyagawa S. (2008) Increased expression of thioredoxin- 1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. Hum. Pathol. 39:201-208.
29. Raffel J, et al. (2003) Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J. Lab. Clin. Med. 142:46-51.
30. Grogan TM, et al. (2000) Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum. Pathol. 31:475-481.
31. Perez EA. (2009) Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol. Cancer Ther. 8:2086-2095.
32. Miglarese MR, Carlson RO. (2006) Development of new cancer therapeutic agents targeting mitosis. Expert Opin. Investig. Drugs. 15:1411-1425.
33. Carlson RO. (2008) New tubulin targeting agents currently in clinical development. Expert Opin. Investig. Drugs. 17:707-722.
34. Blackhall FH, et al. (2004) Validating the prognostic value of marker genes derived from a nonsmall cell lung cancer microarray study. Lung Cancer. 46:197-204.
35. Jiang WG, et al. (2003) Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin. Cancer Res. 9:6432-6440.
36. Ding J, et al. (2010) Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat. Cell Biol. 12:390-399.